e-ISSN: Pending
Negative / Null Result Report

Safety and Pharmacokinetics of Intravitreally Repeatedly Injected Panitumumab in Non-Human Primates - A Study Performed Under Good Laboratory Practice

Wang YX; Holz FG; Coenen M; Sun X; Xie W; Panda-Jonas S; Dong L; Jonas JB · 2026 · Preprint

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract (excerpt)

Abstract Background Epidermal growth factor (EGF) has been suggested to play a role in myopic axial elongation, and EGF receptor blockade may be of potential therapeutic benefit. Here we examined the ocular and systemic toxicity of…

Excerpt shown for reference under fair use — read the full paper at the publisher.

Read full paper at publisher

Hosted by the publisher — may require access.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: Europe PMC · DOI 10.21203/rs.3.rs-8501876/v1